Analyst: Upgraded ALK sales guidance could still be beaten
Second-quarter sales developments were solid at ALK, and there is a chance that the firm will surpass its upgraded expectations, or at least land at the upper end of the scale, says Sydbank analyst Søren Løntoft Hansen.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
ALK releases surprisingly strong quarterly figures
For subscribers
ALK expects to have approved peanut allergy vaccine in 2030
For subscribers